TP53 and cholangiocarcinoma: Similar negative association between TP53 mutation and clinical outcomes was also observed in BTC patients undergoing surgery treatment37 We demonstrate, for the first time to our knowledge, the potentially distinctive prognosis between young and old CCA patients might be rationalized by different prevalence of genetic alterations, whereas larger study cohorts with diverse ethnic groups are required to further confirm our findings.